Injection site hypersensitivity: Which Medications Cause It? (2,453 Reports Across 97 Drugs)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Injection site hypersensitivity has been reported as an adverse event with 97 different drugs in the FDA's FAERS database, with 2,453 total reports. 19 of these reports resulted in death.The drugs most commonly associated with Injection site hypersensitivity are ETANERCEPT, TIRZEPATIDE, and ADALIMUMAB.
2,453
Total Reports
97
Drugs Involved
19
Deaths
231
Hospitalizations
50.2 yrs
Average Patient Age
82.1% / 17.9%
Female / Male
Which Drugs Cause Injection site hypersensitivity Most Often?
| Drug | Reports | % of Drug Reports | Deaths | Hosp. | Life-Threat. |
|---|---|---|---|---|---|
| ETANERCEPT | 363 | 0.1% | 1 | 25 | 1 |
| TIRZEPATIDE | 333 | 0.3% | 0 | 3 | 0 |
| ADALIMUMAB | 295 | 0.1% | 1 | 44 | 0 |
| DUPILUMAB | 125 | 0.0% | 0 | 2 | 0 |
| TOCILIZUMAB | 103 | 0.1% | 1 | 23 | 0 |
| METHOTREXATE | 82 | 0.0% | 0 | 21 | 0 |
| DULAGLUTIDE | 73 | 0.1% | 0 | 2 | 0 |
| IXEKIZUMAB | 71 | 0.2% | 0 | 2 | 1 |
| OCTREOTIDE | 67 | 0.3% | 11 | 22 | 3 |
| ANAKINRA | 60 | 0.5% | 0 | 22 | 0 |
| GLATIRAMER | 60 | 0.1% | 0 | 5 | 0 |
| GALCANEZUMAB-GNLM | 57 | 0.2% | 0 | 0 | 0 |
| EVOLOCUMAB | 55 | 0.0% | 0 | 3 | 0 |
| RITUXIMAB | 50 | 0.0% | 0 | 1 | 0 |
| CYCLOPHOSPHAMIDE | 47 | 0.0% | 0 | 17 | 0 |
| INFLIXIMAB | 46 | 0.0% | 0 | 23 | 0 |
| OMALIZUMAB | 44 | 0.1% | 0 | 14 | 1 |
| AZATHIOPRINE | 41 | 0.1% | 0 | 20 | 0 |
| INCOBOTULINUMTOXINA | 41 | 0.9% | 1 | 1 | 1 |
| PREDNISOLONE | 40 | 0.1% | 0 | 20 | 0 |